Individual Study / CAPRICORN

Cardvedilol Post Infarct Survival Control in Left Ventricular Dysfunction

Cardvedilol Post Infarct Survival Control in Left Ventricular Dysfunction

Initiatives -
We investigated the long-term efficacy of carvedilol on morbidity and mortality in patients with left-ventricular dysfunction after acute myocardial infarction treated according to current evidence-based practice. *Note: All published information has been collected from the article referenced in the Marker Paper box below. Therefore, there may be variations with more advanced versions of the study.*

Members

Download
Investigators Contacts
  • Prof. Henry Dargie
    Robertson Centre for Biostatistic

Design

Study design
Clinical trial
Follow Up
Patients were followed up until the requisite number of primary endpoints had occurred

Marker Paper

Dargie HJ. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet. 2001 May 5;357(9266):1385-90. doi: 10.1016/s0140-6736(00)04560-8.

PUBMED 11356434

Recruitment

Sources of Recruitment
  • Individuals

Number of participants

Number of participants
1,959
Number of participants with biosamples

Access

Availability of data and biosamples

Data
Biosamples
Other